The EU pays more than 1 billion euros for Remdesivir October 13, 2020September 21, 2022 Coronaheadsup.com Coronavirus, Europe, Health, Remdesivir, Treatment The European Union has agreed to pay more than 1 billion euros to Gilead for a six-month supply of its antiviral drug remdesivir, shortly before the publication of final results of the biggest trial of the COVID-19 medication. Reuters report ** This post was originally published on October 13, 2020 **Share this:Tweet Related Posts: Prof Arne Burkhardt: 2nd Conference on Vaccine Adverse EventsXBB.1.16 is the second most common variant in the USCensored by Youtube: Dr John Campbell on 14yr old Japanese girl who died two days after third dose…Are bluetooth mac addresses given off by vaccinated individuals?SARS-CoV-2 spike protein accumulates in the brainH5N1 Human Bird Flu Infection in Chile *3 Updates*
